The Patent Finder
US

Cancer Treatment

US 11,077,106 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Janssen Research & Development, LLC, an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Feb 2, 2038 · High confidence

Filed Aug 5, 2019 as application 16/483,579 · Granted Aug 3, 2021
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
Feb 2, 2018
Term ends
Feb 2, 2038
Granted
Aug 3, 2021
base term fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 2, 2018, when application PCT/EP2018/052694, the earliest non-provisional in its chain, was filed (this one was filed Aug 5, 2019)Feb 2, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderFeb 2, 2038High confidence

This family

US 11,077,106this patent
Feb 2038
Feb 2038
Application 17/360,618Abandoned
not computed
not computed
Application 19/302,199Pending
not computed
not computed
3 of 4 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 7, 2020
Reel 53432, frame 722
Avadhani, Anjali NarayanJanssen Pharmaceuticals Inc.Assignment of Assignor's Interest
Aug 7, 2020
Reel 53432, frame 809
Loriot, YohannInstitut Gustave RoussyAssignment of Assignor's Interest
Aug 7, 2020
Reel 53433, frame 108
Siefker-radtke, Arlene OThe University of Texas M.D. Anderson Cancer, a State Institution of Higher EducationAssignment of Assignor's Interest
Aug 7, 2020
Reel 53433, frame 173
The Board of Regents of the University of Texas SystemJanssen Research & Development, LLCAssignment of Assignor's Interest
Aug 7, 2020
Reel 53433, frame 344
Stuyckens, Kim; De Porre, Peter Marie Z.Janssen Pharmaceutica N.V.Assignment of Assignor's Interest
Aug 7, 2020
Reel 53433, frame 362
Janssen Pharmaceuticals Inc.Janssen Pharmaceutica N.V.Assignment of Assignor's Interest
Aug 7, 2020
Reel 53433, frame 564
Institut Gustave RoussyJanssen Research & Development, LLCAssignment of Assignor's Interest
Aug 7, 2020
Reel 53433, frame 766
Janssen Research & Development, LLCJanssen Pharmaceutica N.V.Assignment of Assignor's Interest
Aug 7, 2020
Reel 53433, frame 799
Janssen-cilag, S.a.Janssen Pharmaceutica N.V.Assignment of Assignor's Interest
Aug 25, 2020
Reel 53597, frame 867
Perez Ruixo, Juan JoseJanssen-cilag, S.a.Assignment of Assignor's Interest
Feb 24, 2021
Reel 55383, frame 802
Perez Ruixo, Juan JoseJanssen-cilag, S.a.Assignment of Assignor's Interest
Nov 8, 2022
Reel 61697, frame 46
Janssen Research & Development, LLCJanssen Pharmaceutica N.V.Assignment of Assignor's Interest
Nov 8, 2022
Reel 61697, frame 251
Siefker-radtke, Arlene O.Board of Regents of the University of Texas SystemAssignment of Assignor's Interest
Nov 8, 2022
Reel 61697, frame 336
Janssen-cilag, S.a.Janssen Pharmaceutica N.V.Assignment of Assignor's Interest
Nov 8, 2022
Reel 61697, frame 521
Institut Gustave RoussyJanssen Research & Development, LLCAssignment of Assignor's Interest
Nov 8, 2022
Reel 61697, frame 653
Janssen Pharmaceuticals, Inc.Janssen Pharmaceutica N.V.Assignment of Assignor's Interest
Nov 8, 2022
Reel 61697, frame 724
Avadhani, Anjali NarayanJanssen Research & Development, LLCAssignment of Assignor's Interest
Jan 6, 2023
Reel 62301, frame 250
O'hagan, AnneJanssen Research & Development, LLCAssignment of Assignor's Interest
Mar 24, 2023
Reel 63095, frame 115
Avadhani, Anjali NarayanJanssen Research & Development, LLCAssignment of Assignor's Interest
Mar 24, 2023
Reel 63095, frame 593
Stuyckens, KimJanssen Pharmaceutica N.V.Assignment of Assignor's Interest
Mar 24, 2023
Reel 63097, frame 589
De Porre, Peter Marie Z.Janssen Pharmaceutica N.V.Assignment of Assignor's Interest
Mar 24, 2023
Reel 63098, frame 43
Perez Ruixo, Juan JoseJanssen-cilag, S.a.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited